In a subsequent prospective study, serial plasma samples from 120 children who met the inclusion and exclusion criteria were assayed for NGAL using the Triage® device to assess its ability to predict AKI and other adverse outcomes. This evidence concerns the gene LCN2 and acute kidney injury.